Physician

Usah Lilavivat, MD

According to 2025 Medicare claims, Usah Lilavivat, MD (NPI: 1437241262) practices endocrinology in the Sumter, SC market, with the plurality of this provider's patient population coming from Sumter, SC. This provider's primary affiliated billing organization is MUSC COMMUNITY PHYSICIANS (NPI: 1841878006; TIN: 853861695) and primary practice location at 29150-1900. Lilavivat is affiliated with the MUSC Health Alliance, LLC (ACO ID: A5535), participating under the MSSP model.

Lilavivat's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 572 traditional Medicare patients, billed 12,160 HCPCS/CPT codes, and received $383,364 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,630 prescription claims across 289 beneficiaries totaling $2,724,979 in drug costs, led by Korlym (Mifepristone). DME data shows 556 claims. Open Payments data shows 62 records totaling $1,375. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $189,250 to $383,364. Similarly, Part D prescription costs have moved sharply higher in recent years, from $560,902 to $2,724,979. For DME billing, reported payments moved from a lower plateau to a higher plateau, from $36,601 to $114,180.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	474	6,941	$189,250
2016	493	8,339	$232,327
2017	1,169	16,602	$423,934
2018	1,308	15,274	$356,250
2019	770	11,580	$265,248
2020	434	17,088	$249,484
2021	703	29,982	$421,109
2022	795	45,398	$649,831
2023	713	29,685	$482,714
2024	572	12,160	$383,364

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	317	4,177	$560,902
2016	223	3,562	$584,177
2017	444	4,461	$848,876
2018	454	4,268	$919,636
2019	322	2,942	$860,022
2020	263	2,572	$1,243,388
2021	284	2,593	$2,410,409
2022	362	2,620	$2,154,395
2023	352	2,614	$2,565,922
2024	289	2,630	$2,724,979

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	330	949	$195,161
2016	246	695	$185,003
2017	182	698	$140,739
2018	203	812	$150,422
2019	127	715	$137,650
2020	125	714	$146,708
2021	105	773	$160,087
2022	106	786	$178,555
2023	101	769	$180,052
2024	99	556	$203,515

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	375	450	$87
84443	Blood test, thyroid stimulating hormone (tsh)	271	438	$16
80053	Blood test, comprehensive group of blood chemicals	354	562	$10
83036	Hemoglobin a1c level	321	464	$9
36415	Insertion of needle into vein for collection of blood sample	456	755	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Korlym	Mifepristone	53	1,590	$1,900,545
Mounjaro	Tirzepatide	156	4,794	$175,507
Ozempic	Semaglutide	100	3,833	$126,983
Jardiance	Empagliflozin	112	5,520	$104,547
Trulicity	Dulaglutide	28	1,681	$54,837

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	47	189	$81,648
B4189	Parenteral nutrition solution; compounded amino acid and carbohydrates with electrolytes, trace elements, and vitamins, including preparation, any strength, 10 to 51 grams of protein - premix	N	N/R	52	$72,037
E0784	External ambulatory infusion pump, insulin	Y	N/R	38	$13,076
A4224	Supplies for maintenance of insulin infusion catheter, per week	N	13	44	$10,381
B4224	Parenteral nutrition administration kit, per day	N	N/R	52	$9,964

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	62	$1,375	Amgen Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Usah Lilavivat, MD?

Tedicare shows public-source Medicare data for Usah Lilavivat, MD (NPI 1437241262), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Usah Lilavivat, MD have ACO affiliation data?

Usah Lilavivat, MD is shown with ACO affiliation data for MUSC Health Alliance, LLC (MSSP, ACO ID A5535).

What billing organization is linked to Usah Lilavivat, MD?

Usah Lilavivat, MD is linked to MUSC COMMUNITY PHYSICIANS (billing NPI 1841878006) in the available physician profile data.

Does Usah Lilavivat, MD have Open Payments data?

Usah Lilavivat, MD has 62 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.